User profiles for "author:JF Simard"
Julia F SimardAssociate Professor of Epidemiology & Population Health, and Immunology & … Verified email at stanford.edu Cited by 8344 |
Predictive value of S-100β protein for prognosis in patients with moderate and severe traumatic brain injury: systematic review and meta-analysis
Objectives To determine the ability and accuracy of the S-100β protein in predicting
prognosis after a moderate or severe traumatic brain injury. Design Systematic review and …
prognosis after a moderate or severe traumatic brain injury. Design Systematic review and …
Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies
Previous studies of stroke in systemic lupus erythematosus (SLE) have had limited statistical
power, combined stroke subtypes into composite outcomes, and lacked a reference …
power, combined stroke subtypes into composite outcomes, and lacked a reference …
[HTML][HTML] The representation of gender and race/ethnic groups in randomized clinical trials of individuals with systemic lupus erythematosus
…, Y Chaichian, MB Bass, JF Simard - Current rheumatology …, 2018 - Springer
Abstract Purpose of Review This review evaluated gender and race/ethnic representation in
randomized controlled trials (RCTs) of patients with systemic lupus erythematosus (SLE) …
randomized controlled trials (RCTs) of patients with systemic lupus erythematosus (SLE) …
Mortality associated with withdrawal of life-sustaining therapy for patients with severe traumatic brain injury: a Canadian multicentre cohort study
Background: Severe traumatic brain injury often leads to death from withdrawal of life-
sustaining therapy, although prognosis is difficult to determine. Methods: To evaluate …
sustaining therapy, although prognosis is difficult to determine. Methods: To evaluate …
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
Background We describe the early experiences of adults with systemic rheumatic disease
who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted …
who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted …
Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden
M Neovius, JF Simard, J Askling… - Annals of the …, 2011 - ard.bmj.com
Objective To provide Swedish nationwide data on the prevalence of rheumatoid arthritis
(RA), including variations by age, sex, geography, demography and education level, and …
(RA), including variations by age, sex, geography, demography and education level, and …
Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden
P Raaschou, JF Simard, M Holmqvist, J Askling - Bmj, 2013 - bmj.com
Objectives To investigate the potential association between tumour necrosis factor (TNF)
inhibitor treatment and malignant melanomas in rheumatoid arthritis, melanoma risks in …
inhibitor treatment and malignant melanomas in rheumatoid arthritis, melanoma risks in …
Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
…, JK Eriksson, LE Kristensen, JF Simard… - Annals of the …, 2015 - ard.bmj.com
Objective To compare drug survival on adalimumab, etanercept and infliximab in patients
with rheumatoid arthritis (RA). Methods Patients with RA (n= 9139; 76% women; mean age …
with rheumatoid arthritis (RA). Methods Patients with RA (n= 9139; 76% women; mean age …
Incidence of rheumatoid arthritis in Sweden: a nationwide population‐based assessment of incidence, its determinants, and treatment penetration
…, S Ernestam, S Lindblad, JF Simard… - Arthritis care & …, 2013 - Wiley Online Library
Objective To estimate the nationwide incidence of rheumatoid arthritis (RA) in Sweden,
including its variation across age, sex, geography, and demography, and to describe the …
including its variation across age, sex, geography, and demography, and to describe the …
Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis
Background: Acquired drug resistance or gradual drug failure has been described with most
disease modifying antirheumatic drugs (DMARDs) and is also starting to be recognised with …
disease modifying antirheumatic drugs (DMARDs) and is also starting to be recognised with …